Mendus to participate in several investor and industry conferences in January

Press release Stockholm, Sweden, January 8, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...

Related Keywords

Stockholm ,Sweden ,United States ,San Francisco ,California ,Netherlands ,Erik Manting ,Morgan ,Healthcare Conference ,Annual Lifesci Partners Corporate Access ,Lifesci Corporate Access ,Nasdaq Stockholm ,Markets ,